Kruis W, Büll U, Eisenburg J, Paumgartner G
Scand J Gastroenterol. 1982 Oct;17(7):933-8. doi: 10.3109/00365528209181117.
In five patients with inflammatory bowel disease and in two healthy control subjects retrograde spread and colonic distribution of rectally introduced sulphasalazine (SASP) enema were investigated. The SASP enema was labeled with 99mTc and imaged by a gamma camera. In all patients the SASP enema reached the inflamed portion of the colon. From 73% to 84% of the total SASP enema were fairly homogeneously distributed beyond the patients' rectum. The results suggest that patients with inflammatory bowel disease may benefit from SASP enemas even if the total colon is involved.
对5例炎症性肠病患者和2名健康对照者进行了研究,以观察经直肠注入柳氮磺胺吡啶(SASP)灌肠剂的逆行扩散及在结肠中的分布情况。SASP灌肠剂用99mTc标记,并用γ相机成像。在所有患者中,SASP灌肠剂均到达结肠的炎症部位。在患者直肠以外,SASP灌肠剂总量的73%至84%分布相当均匀。结果表明,即使全结肠受累,炎症性肠病患者使用SASP灌肠剂可能也有益处。